To the Editor We write to respond to a recent report by Dr Lalani and colleagues1 regarding device-associated adverse events reported to the US Food and Drug Administration (FDA). Adverse event reports submitted to the MAUDE (Manufacturer and User Facility Device Experience) database2 are an important tool in the postmarket surveillance of medical devices. The FDA provides public access to these data to promote transparency and the opportunity for research and analyses. We write to address the following points.
Ryan M, Myers AM, Yustein AS. Reporting Device-Associated Death Events to the FDA. JAMA Intern Med. 2022;182(4):462. doi:10.1001/jamainternmed.2021.8509
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.